Cardiff Lexington (CDIX)
OTHER OTC:CDIX
Want to see CDIX full AI Analyst Report?
Top Page
Cardiff Lexington
(OTC:CDIX)
Select Model
Select Model
Rating:40Underperform
Price Target:
$1.50
▼(-16.67% Downside)
Action:DowngradedDate:04/17/26
The score is pressured primarily by weak financial performance (heavy recent losses, rising leverage, and persistent negative operating/free cash flow). Technical indicators add additional downside risk with the stock trading far below major moving averages and negative momentum. Valuation provides limited support because the negative P/E reflects ongoing losses and no dividend yield is available.
Positive Factors
Diversified holding model
A diversified holding structure across healthcare, finance and real estate provides durable revenue diversification and risk mitigation. Diverse cash flow sources can smooth cyclical volatility, enable capital allocation across subsidiaries, and support long-term resilience of consolidated earnings.
Negative Factors
Persistent negative cash flow
Chronic negative operating and free cash flow erodes liquidity and forces dependence on external financing. Over months, cash burn increases refinancing risk, limits reinvestment in subsidiaries, and constrains the company's ability to fund strategic initiatives without further leverage or asset disposals.
Read all positive and negative factors
Positive Factors
Negative Factors
Diversified holding model
A diversified holding structure across healthcare, finance and real estate provides durable revenue diversification and risk mitigation. Diverse cash flow sources can smooth cyclical volatility, enable capital allocation across subsidiaries, and support long-term resilience of consolidated earnings.
Read all positive factors
Cardiff Lexington (CDIX) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$21.22M
Dividend YieldN/A
Average Volume (3M)18.00
Price to Earnings (P/E)―
Beta (1Y)-0.04
Revenue Growth64.58%
EPS Growth-104.21%
CountryUS
Employees15
SectorHealthcare
Sector Strength45
IndustryAsset Management
Share Statistics
EPS (TTM)-0.37
Shares Outstanding15,159,403
10 Day Avg. Volume20
30 Day Avg. Volume18
Financial Highlights & Ratios
PEG Ratio0.51
Price to Book (P/B)7.01
Price to Sales (P/S)3.37
P/FCF Ratio-13.62
Enterprise Value/Market Cap2.19
Enterprise Value/Revenue4.03
Enterprise Value/Gross Profit6.44
Enterprise Value/Ebitda42.19
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Cardiff Lexington Business Overview & Revenue Model
Company Description
Cardiff Lexington Corporation, together with its subsidiaries, provides affordable housing and tax resolution services in the United States. It also leases and sells mobile homes and mobile home parks, as well as offers an alternative to tradition...
How the Company Makes Money
Cardiff Lexington makes money through its portfolio of subsidiaries, which generate revenue across distinct industries. Its healthcare operations provide services that contribute to consistent income streams, while its real estate activities inclu...
Cardiff Lexington Financial Statement Overview
Summary
Income Statement
34
Negative
Balance Sheet
28
Negative
Cash Flow
19
Very Negative
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Sep 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 11.54M | 8.27M | 11.85M | 10.69M | 9.88M |
| Gross Profit | 7.21M | 4.43M | 8.29M | 6.63M | 6.11M |
| EBITDA | 1.10M | -107.90K | 5.23M | 3.41M | 2.67M |
| Net Income | -6.54M | -3.30M | 3.03M | -5.43M | 666.29K |
Balance Sheet | |||||
| Total Assets | 29.09M | 23.93M | 20.75M | 13.34M | 15.30M |
| Cash, Cash Equivalents and Short-Term Investments | 318.54K | 1.19M | 866.94K | 219.09K | 580.97K |
| Total Debt | 18.90M | 9.72M | 6.36M | 3.90M | 2.98M |
| Total Liabilities | 26.01M | 16.32M | 14.12M | 14.81M | 14.56M |
| Stockholders Equity | 5.54M | 7.60M | 6.62M | -1.47M | 732.36K |
Cash Flow | |||||
| Free Cash Flow | -2.85M | -2.65M | -1.72M | -1.14M | -1.05M |
| Operating Cash Flow | -2.85M | -2.65M | -1.72M | -1.14M | -1.05M |
| Investing Cash Flow | 0.00 | 0.00 | 0.00 | 3.27M | -2.32M |
| Financing Cash Flow | 1.98M | 2.98M | 2.37M | 788.79K | 3.68M |
Cardiff Lexington Technical Analysis
1.80
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CDIX, the sentiment is undefined. The current price of 1.8 is equal to the 20-day moving average (MA) of ―, equal to the 50-day MA of ―, and equal to the 200-day MA of ―, indicating a neutral trend. The MACD of ― indicates undefined momentum. The RSI at ― is undefined, neither overbought nor oversold. The STOCH value of ― is undefined, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a undefined sentiment for CDIX.
Cardiff Lexington Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
51 Neutral | $34.94M | 20.79 | 38.97% | ― | -37.08% | ― | |
50 Neutral | $49.66M | -16.42 | -14.73% | ― | -10.16% | 13.49% | |
48 Neutral | $42.27M | -63.68 | -5.22% | 0.20% | 261.58% | -329.41% | |
40 Underperform | $21.22M | -5.94 | -55.42% | ― | 64.58% | -104.21% |
* Healthcare Sector Average
CDIX
Cardiff Lexington
1.45
-18.05
-92.56%
MGLD
Marygold Companies
1.12
0.28
32.86%
BCG
Binah Capital Group
1.96
-0.44
-18.33%
RMCO
Royalty Management Holding
2.88
1.68
139.40%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.